prednisone has been researched along with idelalisib in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Antiga, E; Galeone, M | 1 |
| Abella-Dominicis, E; Ansell, SM; Barr, PM; Flowers, CR; Friedberg, JW; Gopal, AK; Kahl, BS; Koh, B; Martin, P; Salles, GA; Ye, W | 1 |
| de Jongh, E; Hengeveld, PJ; Levin, MD; Westerweel, PE | 1 |
1 trial(s) available for prednisone and idelalisib
| Article | Year |
|---|---|
Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Follicular; Male; Prednisone; Purines; Quinazolinones; Recurrence; Rituximab; Survival Rate; Vincristine | 2017 |
2 other study(ies) available for prednisone and idelalisib
| Article | Year |
|---|---|
Multiple mucosal ulcerations caused by idelalisib.
Topics: Dexamethasone; Follow-Up Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mouth Mucosa; Neoplasm Recurrence, Local; Oral Ulcer; Prednisone; Purines; Quinazolinones; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2017 |
Disseminated cryptococcal disease during treatment with idelalisib and corticosteroids for follicular lymphoma.
Topics: Antifungal Agents; Antineoplastic Agents; Cryptococcosis; Glucocorticoids; Humans; Lymphoma, Follicular; Male; Middle Aged; Prednisone; Purines; Quinazolinones | 2020 |